The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
The coming COVID boosters aren't the only vaccines adults should consider. Now's a good time for people over 18 to make sure they're up to date with flu, tetanus, and other routine vaccines.
More than 90% of Americans have been immunized against polio, but the news is still unsettling and has many wondering if they’re at risk of becoming infected or even paralyzed.
Three infectious disease experts at Columbia University Irving Medical Center presented the latest updates on monkeypox at a briefing Aug. 16 for CUIMC faculty, staff, and students.
The monkeypox has recently been declared a public health emergency in the United States and experts have expressed concern that the virus could become endemic.
The latest omicron subvariants—especially the currently dominant BA.4 and BA.5 forms—are even better at eluding vaccines and most treatments, find researchers at Columbia University.
Community outreach and restricting online scheduling to certain zip codes helped increase vaccine uptake among Black and Hispanic residents, new study says.
Columbia scientists have joined a regional consortium to accelerate the development of new drugs that target SARS-CoV-2, other coronaviruses, and viruses that could lead to future pandemics.
In the wake of the COVID pandemic, Anne Moscona is bringing an appreciation for public outreach to her upcoming role as president of the American Society for Virology.
Columbia researchers have uncovered how Gram-negative bacteria—which cause a variety of drug-resistant infections—build their protective outer layer, which could lead to more effective treatments.